EA201991561A3 - FIBRONECTIN-BASED FRAME FRAME DOMAINS WHICH ARE CONNECTED TO MYOSTATIN - Google Patents
FIBRONECTIN-BASED FRAME FRAME DOMAINS WHICH ARE CONNECTED TO MYOSTATINInfo
- Publication number
- EA201991561A3 EA201991561A3 EA201991561A EA201991561A EA201991561A3 EA 201991561 A3 EA201991561 A3 EA 201991561A3 EA 201991561 A EA201991561 A EA 201991561A EA 201991561 A EA201991561 A EA 201991561A EA 201991561 A3 EA201991561 A3 EA 201991561A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- proteins
- frame
- myostatin
- fibronectin
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к основанным на фибронектине каркасным доменным белкам, которые связываются с миостатином. Настоящее изобретение также относится к применению этих белков в терапевтических применениях для лечения мышечной дистрофии, кахексии, саркопении, остеоартрита, остеопороза, сахарного диабета, ожирения, хронического обструктивного заболевания легких, хронического заболевания почек, сердечной недостаточности, инфаркта миокарда и фиброза. Настоящее изобретение дополнительно относится к клеткам, содержащим такие белки, полинуклеотидам, кодирующим такие белки или их фрагменты, а также векторам, содержащим полинуклеотиды, кодирующие белки.The present invention relates to fibronectin-based framework domain proteins that bind to myostatin. The present invention also relates to the use of these proteins in therapeutic applications for the treatment of muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes mellitus, obesity, chronic obstructive pulmonary disease, chronic kidney disease, heart failure, myocardial infarction and fibrosis. The present invention further relates to cells containing such proteins, polynucleotides encoding such proteins or fragments thereof, as well as vectors containing polynucleotides encoding proteins.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780005P | 2013-03-13 | 2013-03-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201991561A2 EA201991561A2 (en) | 2020-03-31 |
EA201991561A3 true EA201991561A3 (en) | 2020-06-30 |
Family
ID=69942786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991561A EA201991561A3 (en) | 2013-03-13 | 2013-09-12 | FIBRONECTIN-BASED FRAME FRAME DOMAINS WHICH ARE CONNECTED TO MYOSTATIN |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201991561A3 (en) |
-
2013
- 2013-09-12 EA EA201991561A patent/EA201991561A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201991561A2 (en) | 2020-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201590543A1 (en) | FIBRONECTIN-BASED FRAMEWORK DOMAIN PROTEINS THAT ASSOCIATE WITH MYOSTATIN | |
EA202091710A1 (en) | ANTIBODIES AGAINST CD73 AND METHODS OF THEIR USE | |
EA201270713A1 (en) | PROTEINS BASED ON FIBRONECTIN WITH FRAMED DOMAINS THAT BIND IL-23 | |
CY1122539T1 (en) | GLUCAGON ANALOGUES | |
MX2015014538A (en) | Trimeric antigen binding molecules. | |
EA202090227A1 (en) | ANTI-LAG-3 ANTIBODY WITH HIGH STABILITY | |
EA201590294A1 (en) | ANALOGUE GLUACAGONA | |
EA201792084A1 (en) | METHODS AND COMPOSITIONS RELATED TO POLYPEPTIDES - GPCR AGONISTS | |
EA201391457A1 (en) | PROTEINS CONNECTING WITH BCMA (CD269 / TNFRSF17) | |
EA201692459A1 (en) | ANTIBODIES TO INDUCED GLUCOCORTICOIDS RECEPTOR OF THE TUMOR NECROSIS FACTOR (GITR) AND THEIR APPLICATIONS | |
AR081221A1 (en) | ANTIBODIES ANTI GDF8 HUMAN | |
EA201791057A1 (en) | ANTIGENSBELTING MOLECULES CONTAINING THERMAL LIGAND OF TNF FAMILIES | |
EA201791577A1 (en) | CONNECTING WITH EGFR AND C-MET MOLECULES WITH FIBRONECTIN TYPE III DOMAINS | |
EA201491470A1 (en) | COMPOSITIONS OF FACTOR VIII AND METHODS OF OBTAINING AND USING SIMILAR | |
EA201890613A1 (en) | POLYPEPTIDES CONNECTING CD3 | |
EA201600338A1 (en) | BISPECIFIC BINDING MOLECULE CONNECTING VEGF AND ANG2 | |
EA201000238A1 (en) | ANTIGEN-BINDING PROTEINS FOR IL-18 RECEPTOR AND THEIR APPLICATION | |
EA201791940A3 (en) | OPTIONS OF POLYPEPTIDES OF ACTIVIN IIB RECEPTOR AND THEIR USE | |
EA201890172A1 (en) | TAU-BINDING ANTIBODIES | |
NZ721984A (en) | Immunoglobulin-like molecules directed against fibronectin-eda | |
CR20180311A (en) | IMPROVED TNF BINDERS | |
EA201591898A1 (en) | ANTIBODIES DIRECTED TO M-CSF | |
EA201991561A3 (en) | FIBRONECTIN-BASED FRAME FRAME DOMAINS WHICH ARE CONNECTED TO MYOSTATIN | |
MX2017007663A (en) | Immunoglobulin-like molecules directed against fibronectin-eda. | |
MA37981B1 (en) | Fibronectin-based scaffold domain proteins that bind to myostatin |